Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $376.1M |
| Sales growthchange from the year before | +91.3% |
| Gross marginshare of sales left after the direct cost of what it sells | 90.2% |
| Operating marginshare of sales left after running the business | -3.3% |
| Net marginshare of sales kept as profit | -4.3% |
| Free-cash-flow marginspare cash generated per $100 of sales | -1.7% |
| Return on invested capitalprofit made on each $100 put into the business | -3.2% |
| Return on equityprofit vs. shareholders' accounting value | -8.5% |
| Debt / equitydebt vs. shareholders' accounting value | 0.58 |
| Change in share countnegative = the company is buying back its shares | +5.2% |
3 insiders sold $171K (all under pre-arranged plans) on the open market.
| Watanabe ToddSee Remarks · Director | Sold (plan)Aug 3 | 4,375 shat $26.12 · $114K |
| Matsuda MasaruSee Remarks | Sold (plan)Aug 3 | 1,230 shat $26.12 · $32K |
| Burnett PatrickSee Remarks | Sold (plan)Aug 3 | 955 shat $26.12 · $25K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy